作者
Yongliang Jia, Fangyi Huang, Shikai Zhang, Siu-wai Leung
发表日期
2012/6/14
来源
International journal of cardiology
卷号
157
期号
3
页码范围
330-340
出版商
Elsevier
简介
BACKGROUND
Danshen dripping pill (DSP) is a popular Chinese medicinal product and often compared with isosorbide dinitrate (ISDN) in treating coronary heart disease angina pectoris. Over 100 randomized controlled trials (RCT) have been published in Chinese language but have not been evaluated according to the PRISMA systematic review standard. This study aims to provide a comprehensive and PRISMA-compliant systematic review with sensitivity and subgroup analyses.
METHODS
RCTs published between 1994 and 2009 on DSP versus ISDN in treating angina pectoris for 4 or more weeks were retrieved from major databases, including PubMed, Chinese National Knowledge Infrastructure, and WanFang Data. Meta-analysis was performed on the overall effects on symptomatic and electrocardiography (ECG) improvements. Sensitivity analysis was conducted on the study quality of RCTs based on a …
引用总数
201220132014201520162017201820192020202120222023202488517161198105341